Catalytic activity of antibody light chain to gp41: A consideration of refolding in relation to activation mechanism

Chemical Immunology

Volumn 77, Issue , 2000, Pages 18-32

  Uda, T ^a   Hifumi, E ^a   Ohara, K ^a   Zhou, Y ^a  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CATALYTIC ANTIBODY; EDETIC ACID; FERRIC ION; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CATALYSIS; FLUORESCENCE SPECTROSCOPY; IMMUNIZATION; IMMUNOBLOTTING; MYELOMA CELL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0033811670     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058795     Document Type: Article

References (34)

1. Catalytic antibodies
2. Selective chemical catalysis by an antibody
3. Sequence-specific peptide cleavage catalyzed by an antibody
4. Antibody-catalyzed porphyrin metallation
5. Hapten design for the generation of catalytic antibodies
6. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody
7. Peptidolytic monoclonal antibody by a neuropeptide
8. Proteolytic activity of an antibody light chain
9. Destruction of gp41 of HIV-1 envelope by its catalytic antibody light chain
10. Super catalytic antibody. I: Decomposition of targeted protein by its antibody light chain
11. How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1
12. Anti-idiotypic antibodies exhibiting an acetylcholinesterase activity
13. Amidase activity of human Bence Jones proteins
14. Natural catalytic antibodies: Peptide-hydrolyzing activities of Bence Jones proteins and VL fragment
15. Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginyglycinamide bond
16. DNA-hydrolyzing activity of Bence Jones proteins
17. Is the catalytic activity of Bence Jones proteins an autoimmune effector mechanism in multiple myeloma?
18. Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus
19. Catalytic activity of anti-thyroglobulin antibodies
20. DNA hydrolyzing autoantibodies
21. DNA-hydrolyzing autoantibodies
22. Vasoactive intestinal peptide hydrolysis by antibody light chains
23. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain
24. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chain selected by phage display
25. Do immunogloblins have proteolytic activity?
26. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
27. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein
28. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera
29. An approach for an immunoaffinity AIDS sensor using the conservative region of the HIV envelope protein (gp41) and its monoclonal antibody
30. Preparation of monoclonal antibodies against methamphetamine
31. Analysis of the antigen recognition sites for anti methamphetamine monoclonal antibodies (I)
32. Altered cleavage site preference of a proteolytic antibody light chain induced by denaturation
33. Molecular cloning of a proteolytic antibody light chain
34. Mono- and bivalent antibody fragments produced in Escherichia coli: Engineering, folding and antigen binding